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INTRODUCTION
Cardiovascular disease is one of the leading causes of 
death in the western world, with coronary artery disease 
accounting for >10% of all deaths in the UK in 2017.1 The 
burden of cardiovascular disease in patients investigated for 
non- cardiovascular disease is high, with almost the same 
number of deaths attributable to cardiovascular disease as 
lung cancer in the National Lung Screening Trial.2 Identi-
fication of coronary artery disease enables early interven-
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ABSTRACT
Incidental coronary and cardiac calcification are frequent findings on non- gated thoracic CT. We recommend that the 
heart is reviewed on all CT scans where it is visualised. Coronary artery calcification is a marker of coronary artery 
disease and it is associated with an adverse prognosis on dedicated cardiac imaging and on non- gated thoracic CT 
performed for non- cardiac indications, both with and without contrast. We recommend that coronary artery calcifi-
cation is reported on all non- gated thoracic CT using a simple patient- based score (none, mild, moderate, severe). 
Furthermore, we recommend that reports include recommendations for subsequent management, namely the assess-
ment of modifiable cardiovascular risk factors and, if the patient has chest pain, assessment as per standard guide-
lines. In most cases, this will not necessitate additional investigations. Incidental aortic valve calcification may also be 
identified on non- gated thoracic CT and should be reported, along with ancillary findings such as aortic root dilation. 
Calcification may occur in other parts of the heart including mitral valve/annulus, pericardium and myocardium, but in 
many cases these are an incidental finding without clinical significance.
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significantly reduce future coronary events.3 Diagnostic tools 
that provide further opportunities to detect coronary artery 
disease, therefore, have the potential to reduce the burden of 
associated morbidity and mortality.
Given the >5.5 million CT scans were performed in the UK 
in 2018–19, we estimate that ~950 000 thoracic CT scans are 
performed annually in the UK.4 A significant increase in the 
number of low- dose chest CT scans in the UK is expected with 
the expansion of the Targeted Lung Health Checks Program 
from 2020.5 In patients undergoing lung cancer screening, one- 
third of patients are at a high cardiovascular risk but are not 
taking statin therapy.6 The heart is an important component 
of all imaging involving the chest. Cardiac pathology may be 
asymptomatic or provide an explanation for the patient’s presen-
tation. Cardiac and respiratory diseases share risk factors, such 
as smoking, and pathogenic mechanisms, such as inflammation. 
Furthermore, review of the heart may identify cardiac sequelae 
of lung disease.
The aim of this joint guideline from the British Society of 
Cardiovascular Imaging/British Society of Cardiac Computed 
Tomography (BSCI/BSCCT) and British Society of Thoracic 
Imaging (BSTI) is to provide guidance for radiologists regarding 
the reporting of incidental coronary and cardiac calcification 
on routine thoracic CT performed for non- cardiac indications 
without electrocardiogram (ECG) gating (Figures  1 and 2). In 
particular, we recommend the reporting of coronary artery calci-
fication (CAC) when visualised on all CT scans. We also provide 
guidance on how to classify the severity of CAC on a per patient 
basis and aim to increase the awareness of the prognostic impli-
cations of CAC.
Recommendation 1: the heart should be reviewed on all 
CT scans where it is covered on the imaged field of view.
CORONARY ARTERY CALCIFICATION
CAC can be identified as high attenuation material in the path 
of a coronary artery. CAC is an established biomarker for the 
burden of atherosclerosis7,8 with an increase in CAC associated 
with increased risk of cardiovascular events in symptomatic 
and asymptomatic patients.9–16 It is not a method to identify 
the severity of coronary artery stenoses, and significant CAC 
may be present in the absence of flow- limiting coronary artery 
stenoses. Furthermore, coronary artery disease may be present 
in the absence of CAC. A high burden of CAC may be present 
in patients classified as “low risk” by traditional risk factor 
scoring systems and conversely absent in patients classified 
at “high risk”. Combining CAC with traditional risk factors 
can therefore improve coronary artery disease risk stratifica-
tion10,17 and appropriately target statin therapy.18 In addition 
to the early detection of coronary artery disease, the visu-
alisation of CT coronary artery plaque by patients has been 
shown to improve adherence with lifestyle modifications and 
medications.19–21
CAC is formally evaluated using dedicated non- contrast ECG- 
gated cardiac CT, performed with 3 mm contiguous slices and 
a tube voltage of 120 kVp. The Agatston scoring system is the 
most widely used method to assess CAC, although alternatives 
such as the mass and volume scores are available.22 Agatston 
scoring is performed using semi- automated software to iden-
tify areas of calcification (above 130 Hounsfield units), which 
are then weighted based on the maximum attenuation density 
and summed.23 Patients may then be classified into risk groups, 
with CAC score 0 Agatston units (AU) (very low risk), 1–99 
AU (low risk), 100–299 AU (moderate risk), and ≥300 AU (high 
risk).24 Asymptomatic patients with an Agatston score >300 AU 
have a sevenfold increase in the risk of myocardial infarction 
or coronary heart disease death compared to patients with no 
CAC.10
Figure 1. Recommendations for the assessment of cardiac calcification on routine thoracic CT
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Coronary artery calcification on non-gated thoracic 
CT
CAC can be identified on non- gated thoracic CT with an 
excellent diagnostic accuracy compared to gated CT.25,26 
However, CAC is frequently not reported on non- gated thoracic 
CT,27–30 and a recent survey demonstrated only 17% of non- 
cardiothoracic radiologists in Canada were aware of the correla-
tion between CAC scores on gated and non- gated thoracic CT.31 
The incidence of CAC on non- gated thoracic CT performed for 
non- cardiac indications varies from 26 to 93% depending on 
the population assessed.28–30,32–34 It is associated with poorer 
prognosis in a variety of patient cohorts including patients with 
chronic obstructive pulmonary disease, pulmonary embolism, 
cancer and in unselected patients undergoing thoracic CT.32,35–39 
In the National Lung Screening Trial, CAC was associated with 
an increased risk of coronary artery disease- related death, with 
a CAC score of 100–1000 AU associated with a fourfold increase, 
and CAC score of >1000 AU associated with a sevenfold increase 
compared to patients without CAC.35
Reporting coronary calcification
While conventional Agatston scoring remains the gold- standard 
assessment, it requires dedicated software and training. A 
number of semi- quantitative ordinal scoring systems have been 
developed on a per segment, per vessel or per patient basis.35,40,41 
These correlate well with Agatston scoring and their prog-
nostic utility have been established.35,41,42 However, these semi- 
quantitative ordinal scoring systems also take time and training 
to perform.
For non- gated thoracic CT in routine clinical practice, we there-
fore recommend a simple visual ordinal score performed on a 
whole patient basis. CAC is scored as None, Mild, Moderate or 
Severe on a whole patient basis, aiming to summarise the cumu-
lative findings in all the coronary arteries (Figure 3, Supplemen-
tary Material 1). This can be applied to both non- contrast and 
contrast- enhanced images. It provides some stratification of 
patients into risk groups, while being rapid and easy to perform 
in clinical practice. In the National Lung Screening Trial the 
application of a per patient visual assessment identified patients 
at increased risk of subsequent coronary heart disease- related 
death, with good correlation with Agatston scoring, excel-
lent interobserver agreement and acceptability to non- cardiac 
radiologists.35
Recommendation 2: the presence of coronary artery calci-
fication should be identified and quantified using a simple 
per patient visual quantification (none, mild, moderate, 
severe).
Recommendation 3: if coronary artery calcification is 
identified simple recommendations regarding further 
assessment/management should be provided in the report 
text.
CAC is a frequent finding on thoracic CT and is not necessarily 
an indication for further imaging or referral to a cardiologist. 
Instead, review of the clinical features and cardiovascular risk 
factors is recommended, usually by the general practitioner or 
referring physician. If patients are symptomatic with suspected 
Figure 2. Flow diagram for the assessment of coronary artery calcification and cardiac valve calcification on routine thoracic CT.
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coronary artery disease. they should be managed as per standard 
guidelines (e.g. NICE CG95 2016 revision or SIGN 151). If they 
are asymptomatic, we recommend the referrer or general practi-
tioner review and consider modifiable cardiovascular risk factors 
and manage these as per standard guidelines (e.g. NICE CG 
181). For asymptomatic patients, there is no current evidence to 
support further imaging (ischaemia testing, CT coronary angi-
ography or invasive coronary angiography).
It is important to remember that the request for imaging will 
often contain limited ancillary information regarding other 
pathologies or investigations. We, therefore, recommend that 
information regarding CAC is provided to the referring clini-
cian so that they can take this into consideration with the overall 
management of the patient.
We do not recommend an upper age limit for the reporting of 
CAC, nor changing how CAC is reported based on age. The term 
“normal for age” should be avoided, as the risk of cardiovascular 
events increases in proportion to the amount of CAC in all age 
groups. In young patients (<40 years old), the presence of severe 
CAC is unusual, and the assessment of cardiovascular risk factors 
or symptoms is particularly important. Similarly, the presence 
of malignancy is not a reason to ignore CAC, as patients with 
malignancy are at a similar or increased risk of cardiac events 
secondary to the disease process and cardiotoxic therapies. If 
previous coronary intervention is apparent on imaging, such as 
the presence of coronary artery stents or coronary artery bypass 
grafts, then assessment of incidental CAC is not required as the 
presence of coronary artery disease has already been established.
Suggested text that may be included in the summary of the report 
is as follows (Automatic insertion of dictation codes can be used 
to speed this process, Table 1, Supplementary Material 1.
“Mild/Moderate/Severe coronary artery calcification, 
indicating the presence of coronary artery disease. If the 
patient has associated symptoms recommend manage-
ment as per chest pain guidelines (e.g. NICE CG95, SIGN 
151). If the patient is asymptomatic consider reviewing 
modifiable cardiovascular risk factors and managing 
as per guidelines for primary prevention (e.g. NICE CG 
181).”
AORTIC VALVE CALCIFICATION
Aortic valve disease is the most common cardiac valve disease 
in the developed world, with moderate or severe aortic stenosis 
reported in  ~5% of patients aged  >75 years.43,44 The leading 
cause of aortic stenosis is calcific valvular degeneration, although 
Figure 3. Coronary artery calcification severity. Images show different severity of coronary calcification from different patients on 
non- contrast (A–D) and contrast enhanced CT (E–H). Images show no coronary artery calcification (A, E) and mild (B, F), moder-
ate (C, G) and severe (D, H) coronary artery calcification.




Mild/Moderate/Severe coronary artery calcification, indicating the presence of coronary artery disease. If the patient has 
associated symptoms recommend management as per chest pain guidelines (e.g. NICE CG95, SIGN 151). If the patient is 
asymptomatic consider reviewing modifiable cardiovascular risk factors and managing as per guidelines for primary prevention 
(e.g. NICE CG 181).
Aortic valve 
calcification
Moderate/Severe aortic valve calcification. This may indicate the presence of aortic valve stenosis. Consider echocardiography if 
clinically appropriate.
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underlying bicuspid aortic valve (BAV) disease is an important 
consideration in younger patients.43,44 Aortic valve calcification 
on CT is associated with the severity of aortic stenosis assessed 
using echocardiography45–47 and cut- off values for the aortic 
valve Agatston calcium score have been established to identify 
patients with severe stenosis (≥2065 AU for males and ≥1274 AU 
for females).48,49 Aortic valve calcification is also associated with 
the speed of disease progression and an increased risk of adverse 
events, including valve replacement and mortality.45,50,51 Aortic 
valve calcification is of particular utility in cases of low- flow low- 
gradient aortic stenosis where echocardiographic assessment can 
be challenging.52 Consequently, the assessment of aortic valve 
calcification on ECG- gated cardiac CT is now part of the 2017 
ESC/EACTS valvular heart disease guidelines.53 The clinical 
importance of mild aortic valve calcification is currently uncer-
tain, and further evidence is required in this area. An exception 
to this however is patients with bicuspid aortic valves, where 
significant aortic stenosis can occur in the presence of mild 
aortic valve calcification.
Aortic valve calcification on non-gated thoracic CT
Calcification of the aortic valve can be identified as high atten-
uation material in the region of the aortic valve (Figure  4, 
Supplementary Material 1). Care should be taken to differen-
tiate aortic valve calcification from calcification in the aortic 
root, mitral annulus or coronary arteries. The severity of aortic 
valve calcification on non- gated thoracic CT correlates with 
echocardiographic assessment of aortic stenosis.54–56 It is a 
common incidental finding, with its frequency depending on 
the age of the population and indication for imaging.55,57,58 
However, the presence of aortic valve calcification is frequently 
not reported.57
Reporting aortic valve calcification
Agatston scoring of aortic valve calcification can be performed 
on non- gated CT, with good correlation with echocardiographic 
parameters.46,59 However, this is time consuming, and requires 
dedicated software and training. We therefore recommend a 
simple visual ordinal assessment, where aortic valve calcifica-
tion is described as None, Mild, Moderate or Severe (Figure 4). 
This is quick to perform and can be performed on contrast and 
non- contrast images. It also correlates well with formal Agatston 
calcium scoring and with echocardiographic findings.54,55
The presence of moderate or severe aortic valve calcification 
may identify patients who require further assessment such as 
echocardiography. It may also be the cause of presenting symp-
toms such as dyspnoea. However, in many cases the presence 
of aortic valve disease will already be known, and echocardiog-
raphy may have already been performed. For patients with aortic 
valve calcification, the diameter of the aortic root and ascending 
aorta should also be reviewed, on multiplanar reformats where 
possible, as post- stenotic dilation may be apparent even on non- 
contrast imaging. This is not an immediate indication for recall 
for contrast enhanced imaging, but should prompt further assess-
ment of the severity of the aortic stenosis and further assessment 
of aortic anatomy may be required.
Suggested text that can be included in the summary of the report 
is as follows (Automatic insertion of dictation codes can be used 
to speed this process, Table 1):
“Moderate/Severe aortic valve calcification. This may indicate 
the presence of aortic valve stenosis. Consider echocardiography 
if clinically appropriate.”
Recommendation 4: the presence of aortic valve calcifica-
tion should be identified and visual quantification (none, 
mild, moderate, severe) should be performed.
Recommendation 5: if aortic valve calcification is 
identified the diameter of the aortic root and ascending 
thoracic aorta should also be reviewed and simple 
recommendations provided in the report text.
MITRAL, MYOCARDIAL AND PERICARDIAL 
CALCIFICATION
Calcification of the mitral leaflets or mitral annulus is a common 
incidental finding, occurring on approximately 8% of routine 
thoracic CT.60 Mitral leaflet calcification is uncommon and may 
be associated with rheumatic heart disease or advanced renal 
impairment. It is usually subtle and limited to the leaflet tips, 
whereas mitral annular calcification can be extensive, usually 
demonstrating a curvilinear morphology in the posterior and 
outer ring of the valve (Figure 5). Patients with mitral leaflet calci-
fication may require further assessment of mitral valve function 
whereas mitral annular calcification is rarely a therapeutic target. 
It is also important not to mistake mitral annular calcification for 
calcification in the left circumflex coronary artery. Mitral calcifi-
cation can be graded on non- contrast and contrast- enhanced CT 
using a simple visual grading of None, Mild, Moderate or Severe 
(Figure 6).
Figure 4. Aortic valve calcification severity. Images show dif-
ferent severities of aortic valve calcification from different 
patients on non- contrast (A–D) and contrast enhanced CT (E–
L). Multiplanar reformats can help to differentiate aortic valve 
calcification from annular or aortic calcification (I–L). Images 
show no calcification (A, E, I) and mild (B, F, J), moderate (C, 
G, K) and severe (D, H, L) aortic valve calcification.
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Myocardial calcification (Figure  7) usually arises secondary to 
myocardial infarction, although other less common aetiologies 
include trauma, inflammation, neoplastic infiltration, hyper-
trophic cardiomyopathy or infection. Dystrophic myocardial 
calcification associated with infarction has a thin curvilinear 
appearance, with associated myocardial thinning or fatty infil-
tration. Calcification may also occur in the papillary muscles 
(Figure 7). Patients with chronic rheumatic mitral stenosis may 
also demonstrate left atrial wall calcification and patients with 
prior pulmonary vein ablation can develop calcification at the 
ablation sites. Furthermore, unusual calcification patterns may 
occur in patients with adult congenital heart disease, and a clin-
ical history will be of required to interpret this. The significance 
of myocardial calcification will depend on the clinical context 
and indication for imaging.
Pericardial calcification (Figure  7) usually deposits at sites of 
previous pericardial inflammation or fibrosis. Conditions asso-
ciated with pericardial calcification include infection (especially 
viral and tuberculosis), cardiac surgery, trauma, radiotherapy, 
rheumatic heart disease, collagen vascular disease, uraemic 
pericarditis and haemopericardium. Calcified pleural plaques 
on the mediastinal reflection should not be confused for pericar-
dial calcification. The significance of pericardial calcification will 
depend on the clinical context. If ancillary features of constric-
tive pericarditis are identified (Figure 7), then this may warrant 
further investigation.
Recommendation 6: the presence of other calcifications in 
the heart should be identified and reported.
CONCLUSION
The identification of calcification in the coronary arteries can 
provide information on the presence of previously unknown 
coronary artery disease and trigger an assessment of cardiovas-
cular risk factors or associated symptoms such as chest pain. The 
identification of aortic valve calcification may identify patients 
with previously unknown aortic valve disease. Calcification in 
other parts of the heart including the mitral valve, myocardium 
and pericardium may also be identified on thoracic CT. These 
are often asymptomatic and the significance will depend on the 
clinical context.
These guidelines provide recommendations for the reporting of 
coronary, aortic valve and other cardiac calcification identified 
on non- gated thoracic CT performed for non- cardiac indica-
tions. The guidelines are simple and designed for routine clin-
ical use for all radiologists reporting thoracic CT. The use of 
simple visual ordinal scoring systems for coronary and aortic 
valve calcification are designed to minimise the time required to 
implement these guidelines and provide a standardised reporting 
framework that is easily understood by reporters and referrers.
Figure 5. Mitral leaflet and mitral annular calcification. Con-
trast enhanced CT (A) shows mitral leaflet calcification (A, 
yellow arrow) in a patient with mitral valve dysfunction and 
associated enlarged left atrium and pleural effusions. In com-
parison the non- contrast CT (B) shows mitral annular calcifi-
cation (yellow arrows) without clinical sequelae.
Figure 6. Mitral calcification severity. Images show different 
severity of mitral calcification from different patients on non- 
contrast (A–D) and contrast CT (E–H). Images show no calci-
fication (A, E) and mild (B, F), moderate (C, G) and severe (D, 
H) calcification.
Figure 7. Examples of cardiac calcification in other sites 
including (A) pulmonary arteries, (B) papillary muscle, (C, F) 
myocardium and (D, E) pericardium. Image (C) shows myo-
cardial calcification in renal failure and (F) shows myocardial 
calcification in an infarct. (E) shows an example of benign per-
icardial calcification, whereas (D) shows pericardial calcifica-
tion associated with constrictive pericarditis with associated 
atrial enlargement, tubular ventricular morphology, pleural 
effusion and a distended inferior vena cava.
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